UB Paderborn / Katalog / Suche / in CDI

26 – 50 von 174

Sortiert nach

Absence of a Pharmacokinetic Interaction between Losartan and Hydrochlorothiazide

Journal of clinical pharmacology, 1995-12, Vol.35 (12), p.1200-1206

1995

Volltextzugriff (PDF)

Quantitative determination of MK-0767, a dual α/γ peroxisome proliferator-activated receptor (PPAR) agonist, in human plasma by liquid chromatography-tandem mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2004-10, Vol.810 (1), p.7-13

2004

Volltextzugriff (PDF)

Combination therapy with tirofiban and enoxaparin in acute coronary syndromes

International journal of cardiology, 1999-12, Vol.71 (3), p.273-281

1999

Volltextzugriff (PDF)

Pharmacokinetic assessment of an oral enalapril suspension for use in children

Biopharmaceutics & drug disposition, 2000-12, Vol.21 (9), p.339-344

2000

Volltextzugriff (PDF)

The Pharmacokinetics of Enalapril in Children and Infants with Hypertension

Journal of clinical pharmacology, 2001-10, Vol.41 (10), p.1064-1074

2001

Volltextzugriff (PDF)

Pharmacokinetics of Intravenous and Oral Losartan in Patients with Heart Failure

Journal of clinical pharmacology, 1998-06, Vol.38 (6), p.525-532

1998

Volltextzugriff (PDF)

Outcomes of Renal Transplantation in Elderly Patients: Experience From Two Centers

Hong Kong journal of nephrology, 2010-04, Vol.12 (1), p.12-19

2010

Volltextzugriff (PDF)

An improved method for the simultaneous determination of losartan and its major metabolite, EXP3174, in human plasma and urine by high-performance liquid chromatography with fluorescence detection

Journal of pharmaceutical and biomedical analysis, 1997-04, Vol.15 (7), p.1021-1029

1997

Volltextzugriff (PDF)

Biochemical Effects of Losartan, a Nonpeptide Angiotensin II Receptor Antagonist, on the Renin-Angiotensin-Aldosterone System in Hypertensive Patients

Hypertension (Dallas, Tex. 1979), 1995-01, Vol.25 (1), p.37-46

1995

Volltextzugriff (PDF)

PhRMA Perspective on Population and Individual Bioequivalence

Journal of clinical pharmacology, 2000-06, Vol.40 (6), p.561-570

2000

Volltextzugriff (PDF)

DuP 532, an angiotensin II receptor antagonist: First administration and comparison with losartan

Clinical pharmacology and therapeutics, 1997-01, Vol.61 (1), p.59-69

1997

Volltextzugriff (PDF)

A dosing nomogram for continuous infusion intravenous naloxone

Annals of emergency medicine, 1986-05, Vol.15 (5), p.566-570

1986

Volltextzugriff (PDF)

Quantitative determination of a novel insulin sensitizer and its para-hydroxylated metabolite in human plasma by LC–MS/MS

Journal of pharmaceutical and biomedical analysis, 2004-05, Vol.35 (3), p.523-534

2004

Volltextzugriff (PDF)

The Disposition and Bioavailability of Intravenous and Oral Nalbuphine in Healthy Volunteers

Journal of clinical pharmacology, 1987-11, Vol.27 (11), p.866-873

1987

Volltextzugriff (PDF)

Simultaneous determination of a novel thrombin inhibitor and its two metabolites in human plasma by liquid chromatography/tandem mass spectrometry

Journal of pharmaceutical and biomedical analysis, 2000-08, Vol.23 (2), p.607-616

2000

Volltextzugriff (PDF)

Renal Arteriovenous Fistula Presenting as Heart Failure

Hong Kong journal of nephrology, 2006, Vol.8 (2), p.68-70

2006

Volltextzugriff (PDF)

Phenobarbital minimally alters plasma concentrations of losartan and its active metabolite E-3174

Clinical pharmacology and therapeutics, 1996-03, Vol.59 (3), p.268-274

1996

Volltextzugriff (PDF)

Simultaneous determination of a novel M3 muscarinic receptor antagonist and its active 5-OH metabolite in human plasma using liquid chromatography/tandem mass spectrometry

Journal of pharmaceutical and biomedical analysis, 2002-02, Vol.27 (5), p.699-709

2002

Volltextzugriff (PDF)

Update to the PhRMA Perspective on Population and Individual Bioequivalence

Journal of clinical pharmacology, 2000-06, Vol.40 (6), p.571-572

2000

Volltextzugriff (PDF)

Simultaneous determination of a novel angiotensin II receptor blocking agent, losartan, and its metabolite in human plasma and urine by high-performance liquid chromatography

Journal of chromatography, 1992-01, Vol.573 (2), p.295-301

1992

Volltextzugriff (PDF)

Electronic effects in transition metal porphyrins. The reactions of imidazoles and pyridines with a series of para-substituted tetraphenylporphyrin complexes of chloroiron(III)

Journal of the American Chemical Society, 1976-09, Vol.98 (18), p.5552-5560

1976

Volltextzugriff (PDF)

High-performance liquid chromatographic determination of angiotensin II receptor antagonists in human plasma and urine: I. DuP 532 (L-694,492)

Journal of chromatography. Biomedical applications, 1992-10, Vol.581 (1), p.165-170

1992

Volltextzugriff (PDF)

Nonlinear formation of propranolol metabolites in dogs after portacaval transpositions

Journal of pharmacokinetics and biopharmaceutics, 1984-08, Vol.12 (4), p.401-412

1984

Volltextzugriff (PDF)

TREATMENT OF FUNGAL PERITONITIS WITH A COMBINATION OF INTRAVENOUS AMPHOTERICIN B AND ORAL FLUCYTOSINE, AND DELAYED CATHETER REPLACEMENT IN CONTINUOUS AMBULATORY PERITONEAL DIALYSIS

Peritoneal dialysis international, 2008-03, Vol.28 (2), p.155-162

2008

Volltextzugriff (PDF)

The effects of naloxone associated with the intrathecal use of morphine in labor

Anesthesia and analgesia, 1985-07, Vol.64 (7), p.658-666

1985

Volltextzugriff (PDF)

26 – 50 von 174

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(153)
Mit Volltextzugriff
(154)

Publikationsform

Sprache

Englisch
(172)
Japanisch
(21)
Deutsch
(1)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Absence of a Pharmacokinetic Interaction between Losartan and Hydrochlorothiazide

Quantitative determination of MK-0767, a dual α/γ peroxisome proliferator-activated receptor (PPAR) agonist, in human plasma by liquid chromatography-tandem mass spectrometry

Combination therapy with tirofiban and enoxaparin in acute coronary syndromes

Pharmacokinetic assessment of an oral enalapril suspension for use in children

The Pharmacokinetics of Enalapril in Children and Infants with Hypertension

Pharmacokinetics of Intravenous and Oral Losartan in Patients with Heart Failure

Outcomes of Renal Transplantation in Elderly Patients: Experience From Two Centers

An improved method for the simultaneous determination of losartan and its major metabolite, EXP3174, in human plasma and urine by high-performance liquid chromatography with fluorescence detection

Biochemical Effects of Losartan, a Nonpeptide Angiotensin II Receptor Antagonist, on the Renin-Angiotensin-Aldosterone System in Hypertensive Patients

PhRMA Perspective on Population and Individual Bioequivalence

DuP 532, an angiotensin II receptor antagonist: First administration and comparison with losartan

A dosing nomogram for continuous infusion intravenous naloxone

Quantitative determination of a novel insulin sensitizer and its para-hydroxylated metabolite in human plasma by LC–MS/MS

The Disposition and Bioavailability of Intravenous and Oral Nalbuphine in Healthy Volunteers

Simultaneous determination of a novel thrombin inhibitor and its two metabolites in human plasma by liquid chromatography/tandem mass spectrometry

Renal Arteriovenous Fistula Presenting as Heart Failure

Phenobarbital minimally alters plasma concentrations of losartan and its active metabolite E-3174

Simultaneous determination of a novel M3 muscarinic receptor antagonist and its active 5-OH metabolite in human plasma using liquid chromatography/tandem mass spectrometry

Update to the PhRMA Perspective on Population and Individual Bioequivalence

Simultaneous determination of a novel angiotensin II receptor blocking agent, losartan, and its metabolite in human plasma and urine by high-performance liquid chromatography

Electronic effects in transition metal porphyrins. The reactions of imidazoles and pyridines with a series of para-substituted tetraphenylporphyrin complexes of chloroiron(III)

High-performance liquid chromatographic determination of angiotensin II receptor antagonists in human plasma and urine: I. DuP 532 (L-694,492)

Nonlinear formation of propranolol metabolites in dogs after portacaval transpositions

TREATMENT OF FUNGAL PERITONITIS WITH A COMBINATION OF INTRAVENOUS AMPHOTERICIN B AND ORAL FLUCYTOSINE, AND DELAYED CATHETER REPLACEMENT IN CONTINUOUS AMBULATORY PERITONEAL DIALYSIS

The effects of naloxone associated with the intrathecal use of morphine in labor

Suchergebnisse filtern